# Exponent Inc: overview

EXPO · Nasdaq · CIK 851520 · [Industrials](/sectors/industrials.md) · fiscal year ends Jan 1

Pages: [Overview](/companies/expo.md) · [Financials](/companies/expo/financials.md) · [Filings](/companies/expo/filings.md) · [Insiders](/companies/expo/insiders.md)

Latest reported revenue: [$171.6m](/filings/0001193125-26-340211.md) for Q2 FY2026, three months to 2026-07-03, from the 10-Q filed Aug 7, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001193125-26-340211).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-27) | Q4 FY2024 (2025-01-03) | Q1 FY2025 (2025-04-04) | Q2 FY2025 (2025-07-04) | Q3 FY2025 (2025-10-03) | Q4 FY2025 (2026-01-02) | Q1 FY2026 (2026-04-03) | Q2 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [136](/filings/0001193125-25-272273.md) | [137 d](/filings/0001193125-26-082508.md) | [146](/filings/0001193125-26-214572.md) | [142](/filings/0001193125-26-340211.md) | [147](/filings/0001193125-25-272273.md) | [147 d](/filings/0001193125-26-082508.md) | [166](/filings/0001193125-26-214572.md) | [172](/filings/0001193125-26-340211.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [19.0%](/filings/0001193125-25-272273.md) | [19.9% d](/filings/0001193125-26-082508.md) | [30.5%](/filings/0001193125-26-214572.md) | [12.1%](/filings/0001193125-26-340211.md) | [19.7%](/filings/0001193125-25-272273.md) | [19.8% d](/filings/0001193125-26-082508.md) | [24.9%](/filings/0001193125-26-214572.md) | [16.3%](/filings/0001193125-26-340211.md) |
| Net margin | % | [19.1%](/filings/0001193125-25-272273.md) | [17.2% d](/filings/0001193125-26-082508.md) | [18.3%](/filings/0001193125-26-340211.md) | [18.7%](/filings/0001193125-26-340211.md) | [19.1%](/filings/0001193125-25-272273.md) | [16.8% d](/filings/0001193125-26-082508.md) | [17.8%](/filings/0001193125-26-340211.md) | [17.1%](/filings/0001193125-26-340211.md) |
| Diluted EPS | $ per share | [0.50](/filings/0001193125-25-272273.md) | not reported | [0.52](/filings/0001193125-26-214572.md) | [0.52](/filings/0001193125-26-340211.md) | [0.55](/filings/0001193125-25-272273.md) | not reported | [0.59](/filings/0001193125-26-214572.md) | [0.60](/filings/0001193125-26-340211.md) |
| Free cash flow | $m | [28.0 d](/filings/0001193125-25-272273.md) | [53.5 d](/filings/0001193125-26-082508.md) | [5.5](/filings/0001193125-26-214572.md) | [33.9 d](/filings/0001193125-26-340211.md) | [30.0 d](/filings/0001193125-25-272273.md) | [52.9 d](/filings/0001193125-26-082508.md) | [(3.4)](/filings/0001193125-26-214572.md) | [29.1 d](/filings/0001193125-26-340211.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-30) | FY2023 (2023-12-29) | FY2024 (2025-01-03) | FY2025 (2026-01-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [466](/filings/0000950170-24-019390.md) | [513](/filings/0000950170-25-030001.md) | [537](/filings/0001193125-26-082508.md) | [559](/filings/0001193125-26-082508.md) | [582](/filings/0001193125-26-082508.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [23.4%](/filings/0000950170-24-019390.md) | [27.4%](/filings/0000950170-25-030001.md) | [20.7%](/filings/0001193125-26-082508.md) | [21.4%](/filings/0001193125-26-082508.md) | [20.6%](/filings/0001193125-26-082508.md) |
| Net margin | % | [21.7%](/filings/0000950170-24-019390.md) | [19.9%](/filings/0000950170-25-030001.md) | [18.7%](/filings/0001193125-26-082508.md) | [19.5%](/filings/0001193125-26-082508.md) | [18.2%](/filings/0001193125-26-082508.md) |
| Diluted EPS | $ per share | [1.90](/filings/0000950170-24-019390.md) | [1.96](/filings/0000950170-25-030001.md) | [1.94](/filings/0001193125-26-082508.md) | [2.11](/filings/0001193125-26-082508.md) | [2.07](/filings/0001193125-26-082508.md) |
| Free cash flow | $m | [118](/filings/0000950170-24-019390.md) | [81.8](/filings/0000950170-25-030001.md) | [111](/filings/0001193125-26-082508.md) | [138](/filings/0001193125-26-082508.md) | [122](/filings/0001193125-26-082508.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/expo/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $363.4m | 6,184,950 |  | Added +116,138 |
| [KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC](/funds/1021223.md) | 2026-06-30 | $234.8m | 3,995,684 |  | Added +109,376 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $184.7m | 3,143,624 |  | Added +196,868 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $128.1m | 2,180,212 |  | Reduced −30,438 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $114.2m | 1,943,646 |  | Added +54,110 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $102.7m | 1,748,031 |  | Added +100,417 |
| [GENEVA CAPITAL MANAGEMENT LLC](/funds/1009232.md) | 2026-06-30 | $82.6m | 1,405,173 |  | Reduced −390,334 |
| [ROYCE & ASSOCIATES LP](/funds/906304.md) | 2026-06-30 | $77.7m | 1,323,097 |  | Added +178,224 |
| [Conestoga Capital Advisors, LLC](/funds/1163744.md) | 2026-06-30 | $74.4m | 1,265,704 |  | Reduced −640,801 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $71.3m | 1,214,003 |  | Added +141,995 |

## Recent filings

[All 1,535 filings](/companies/expo/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-07 | 16:02 ET | [10-Q](/filings/0001193125-26-340211.md) | Quarterly report, period 2026-07-03 | 0001193125-26-340211 |
| 2026-07-30 | 16:05 ET | [8-K](/filings/0001171843-26-005081.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-005081 |
| 2026-06-10 | 16:05 ET | [8-K](/filings/0001171843-26-004036.md) | 5.07 Shareholder vote results | 0001171843-26-004036 |
| 2026-05-08 | 16:00 ET | [10-Q](/filings/0001193125-26-214572.md) | Quarterly report, period 2026-04-03 | 0001193125-26-214572 |
| 2026-04-30 | 16:05 ET | [8-K](/filings/0001171843-26-002896.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-002896 |
| 2026-04-20 | 16:07 ET | [DEF 14A](/filings/0001193125-26-163945.md) | Proxy statement, period 2026-06-04 | 0001193125-26-163945 |
| 2026-04-06 | 16:35 ET | [8-K](/filings/0001171843-26-002263.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001171843-26-002263 |
| 2026-02-27 | 16:02 ET | [10-K](/filings/0001193125-26-082508.md) | Annual report, period 2026-01-02 | 0001193125-26-082508 |
| 2026-02-05 | 16:05 ET | [8-K](/filings/0001171843-26-000654.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-000654 |
| 2025-11-07 | 16:00 ET | [10-Q](/filings/0001193125-25-272273.md) | Quarterly report, period 2025-10-03 | 0001193125-25-272273 |

## Latest annual report

[Form 10-K for the fiscal year ended Jan 2, 2026](/filings/0001193125-26-082508.md), filed Feb 27, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 851520
- Tickers: EXPO
- Exchange: Nasdaq
- SIC code: 8742 Services-Management Consulting Services
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 16:06 ET. No prices; not investment advice.